DHR

#103
Danaher Corporation
199.39 USD
+2.06%
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
197.31
200.10
Intervallo Annuale
180.03
242.75
Variazione giornaliera
+2.06%
Variazione Mensile
+5.39%
Variazione di 6 mesi
-3.50%
Variazione Annuale
+3.49%
Chiusura Precedente
195.36
Apertura
197.59
Bid
Ask
Minimo
197.31
High
200.10
Volume
1 385
Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche Dividendi
Trimestrale Annuale
  • Market Capitalization 141 B
  • Employee 60 K
  • Founded N/A
  • CEO Rainer M. Blair
  • Website www.danaher.com
  • Headquarter Delaware, United States
  • FIGI BBG000BH3JF8
  • Industry Technology
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
45.33
Rapporto prezzo/fatturato
6.67

Danaher Corporation

Danaher Corporation is an American healthcare company headquartered in Washington, D.C.. It develops products used for advances in biotechnology, life sciences, and diagnostics. The company operates three divisions: biotechnology, which develops products for the development of therapeutics; life sciences, which develops products to identify causes of disease, new therapies, and to test and manufacture new drugs, vaccines and gene editing technologies; and diagnostics, which develops instruments, consumables, and software and services to diagnose diseases. Danaher was founded in 1984 by brothers Steven Rales and Mitchell Rales; it was named after Danaher Creek in Western Montana, where the brothers came up with the idea for the company while fishing. The company is ranked 180th on the Fortune 500 and 241st on the Forbes Global 2000.

Notizie